Innovative approaches to plasminogen activator therapy

Science
E HaberM S Runge

Abstract

Plasminogen activator therapy for acute myocardial infarction has become standard medical practice. Bleeding complications, however, limit the utility of the currently available agents. This article reviews how the tools of molecular biology and protein engineering are being used to develop safer and more effective plasminogen activators.

References

Jun 1, 1987·The Journal of Clinical Investigation·J Loscalzo, D E Vaughan
Apr 1, 1986·Journal of the American College of Cardiology·M L SimoonsA van der Laarse
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A J van ZonneveldH Pannekoek
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J M SchneeT Quertermous
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M S RungeE Haber
Jun 9, 1988·The New England Journal of Medicine·V J Marder, S Sherry
Jun 16, 1988·The New England Journal of Medicine·V J Marder, S Sherry
Oct 1, 1987·Journal of the American College of Cardiology·E BraunwaldR Solomon
Apr 1, 1985·The American Journal of Cardiology·D G MatheyH T Dodge
Jun 1, 1985·The Journal of Clinical Investigation·R L SilversteinR L Nachman
Oct 6, 1983·Nature·C Milstein, A C Cuello
Nov 1, 1984·The Journal of Clinical Investigation·R L SilversteinR L Nachman
Oct 16, 1980·The New England Journal of Medicine·M A DeWoodH T Lang

❮ Previous
Next ❯

Citations

Jul 9, 1999·Journal of Biomedical Materials Research·C A Bense, K A Woodhouse
Apr 1, 1992·Cardiovascular Drugs and Therapy·M Verstraete
Jan 1, 1990·European Journal of Nuclear Medicine·M N Wasser, E K Pauwels
Feb 23, 1990·Pharmaceutisch Weekblad. Scientific Edition·J Drews
Aug 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·P Vermeij
Jul 15, 1990·Biochemical Pharmacology·D Collen, H R Lijnen
Jan 1, 1993·Biotechnology Advances·H R Lijnen, D Collen
Jan 1, 1991·Trends in Cardiovascular Medicine·D E Vaughan, J Loscalzo
May 1, 1992·Trends in Cardiovascular Medicine·I M LubinM S Runge
Dec 19, 2000·Enzyme and Microbial Technology·P JiangB Ru
Dec 15, 1994·The New England Journal of Medicine·E E Weinmann, E W Salzman
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G L ReedE Haber
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M S HershfieldS A Short
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M S RungeD Mullins
Oct 1, 1994·Journal of Internal Medicine·D CollenH Pannekoek
Dec 4, 1992·Annals of the New York Academy of Sciences·H R Lijnen, D Collen
Mar 31, 1995·Annals of the New York Academy of Sciences·A V MaksimenkoM D Smirnov
Jun 21, 1991·Science·T A Waldmann
Nov 22, 2014·Nano LIFE·John N Barry, Alexey A Vertegel
Jun 28, 2000·Archives of Biochemistry and Biophysics·E F SanchezM Richardson
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·G L ReedL Hedstrom
Dec 21, 2000·Letters in Applied Microbiology·R R Chitte, S Dey
Mar 8, 2003·International Journal of Cardiovascular Interventions·Noel M CapliceDavid R Holmes
Nov 1, 1990·The American Journal of the Medical Sciences·R S Williams
May 1, 1990·The American Journal of the Medical Sciences·V E PollakS A Myre
Jan 1, 1990·Annals of the New York Academy of Sciences·A V MaksimenkoV P Torchilin
Dec 14, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sarita S NaikVictor C Yang
Jan 11, 1992·Current Problems in Cardiology·A MaresR Roberts
Sep 1, 1991·Progress in Cardiovascular Diseases·D CollenH K Gold
May 15, 1991·Thrombosis Research·G H RaoJ G White
Dec 1, 1994·Thrombosis Research·M Rodrigues, H Sinzinger
Mar 31, 2004·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Leiliang ZhangBinggen Ru
Jun 1, 1995·Baillière's Clinical Haematology·D Collen, H R Lijnen
Feb 1, 1992·International Journal of Biological Macromolecules·K WelfleD Gerlach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.